Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza
Top Cited Papers
Open Access
- 11 December 2009
- journal article
- research article
- Published by Springer Nature in Critical Care
- Vol. 13 (6) , 1-11
- https://doi.org/10.1186/cc8208
Abstract
Introduction: Human host immune response following infection with the new variant of A/H1N1 pandemic influenza virus (nvH1N1) is poorly understood. We utilize here systemic cytokine and antibody levels in evaluating differences in early immune response in both mild and severe patients infected with nvH1N1. Methods: We profiled 29 cytokines and chemokines and evaluated the haemagglutination inhibition activity as quantitative and qualitative measurements of host immune responses in serum obtained during the first five days after symptoms onset, in two cohorts of nvH1N1 infected patients. Severe patients required hospitalization (n = 20), due to respiratory insufficiency (10 of them were admitted to the intensive care unit), while mild patients had exclusively flu-like symptoms (n = 15). A group of healthy donors was included as control (n = 15). Differences in levels of mediators between groups were assessed by using the non parametric U-Mann Whitney test. Association between variables was determined by calculating the Spearman correlation coefficient. Viral load was performed in serum by using real-time PCR targeting the neuraminidase gene. Results: Increased levels of innate-immunity mediators (IP-10, MCP-1, MIP-1β), and the absence of anti-nvH1N1 antibodies, characterized the early response to nvH1N1 infection in both hospitalized and mild patients. High systemic levels of type-II interferon (IFN-γ) and also of a group of mediators involved in the development of T-helper 17 (IL-8, IL-9, IL-17, IL-6) and T-helper 1 (TNF-α, IL-15, IL-12p70) responses were exclusively found in hospitalized patients. IL-15, IL-12p70, IL-6 constituted a hallmark of critical illness in our study. A significant inverse association was found between IL-6, IL-8 and PaO2 in critical patients. Conclusions: While infection with the nvH1N1 induces a typical innate response in both mild and severe patients, severe disease with respiratory involvement is characterized by early secretion of Th17 and Th1 cytokines usually associated with cell mediated immunity but also commonly linked to the pathogenesis of autoimmune/inflammatory diseases. The exact role of Th1 and Th17 mediators in the evolution of nvH1N1 mild and severe disease merits further investigation as to the detrimental or beneficial role these cytokines play in severe illness.Keywords
This publication has 37 references indexed in Scilit:
- Critical Care Services and 2009 H1N1 Influenza in Australia and New ZealandNew England Journal of Medicine, 2009
- Hospitalized Patients with 2009 H1N1 Influenza in the United States, April–June 2009New England Journal of Medicine, 2009
- The Transmissibility and Control of Pandemic Influenza A (H1N1) VirusScience, 2009
- A Race Against Time to Vaccinate Against Novel H1N1 VirusScience, 2009
- Influenza A(H1N1)v in Germany: the first 10,000 casesEurosurveillance, 2009
- H1N1 Influenza, Public Health Preparedness, and Health Care ReformNew England Journal of Medicine, 2009
- Europe’s initial experience with pandemic (H1N1) 2009 - mitigation and delaying policies and practicesEurosurveillance, 2009
- After Delays, WHO Agrees: The 2009 Pandemic Has BegunScience, 2009
- Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in HumansNew England Journal of Medicine, 2009
- Epidemiology of new influenza A (H1N1) virus infection, United Kingdom, April – June 2009Eurosurveillance, 2009